Innovative antifibrotic therapies in systemic sclerosis

C Beyer, O Distler, JHW Distler - Current opinion in rheumatology, 2012 - journals.lww.com
C Beyer, O Distler, JHW Distler
Current opinion in rheumatology, 2012journals.lww.com
Many antifibrotic candidate therapies have proven efficacy and tolerability in preclinical
models of SSc. So far, early clinical studies have tested only few of these agents. Besides
discovering novel molecular treatment strategies, SSc research will now have to translate its
findings into clinical practice.
Summary
Many antifibrotic candidate therapies have proven efficacy and tolerability in preclinical models of SSc. So far, early clinical studies have tested only few of these agents. Besides discovering novel molecular treatment strategies, SSc research will now have to translate its findings into clinical practice.
Lippincott Williams & Wilkins